Enteric Glial Cells (EGCs) are a crucial component of the enteric nervous system (ENS), which is often referred to as the "second brain" due to its complex neural network in the gastrointestinal tract. EGCs are primarily found in the gut lining, where they support various functions related to digestion and gut homeostasis. Serving as the structural backbone of the ENS, EGCs play a role in regulating motility, secretion, and immune responses within the gastrointestinal tract. They communicate with neurons, immune cells, and the epithelium, contributing to the intricate balance of gut functions. EGCs are involved in sensing changes in the gut environment and responding to various stimuli, including mechanical and chemical signals. Moreover, these glial cells participate in the maintenance of the intestinal barrier and modulate inflammatory processes. Research suggests that EGCs influence gut-brain communication, impacting both gastrointestinal and neurological health. Dysfunction of EGCs has been implicated in gastrointestinal disorders, such as inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). Understanding the roles of enteric glial cells provides insights into the intricate interplay between the gut and nervous system, offering potential avenues for therapeutic interventions in gastrointestinal disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy